Cargando…
Esketamine for treatment‑resistant depression: A review of clinical evidence (Review)
Treatment-resistant depression (TRD) is a challenge for psychiatrists, even after more than seven decades since the first antidepressants were used in clinical practice. Non-monoaminergic-based drugs with antidepressant properties have been developed, but to date, only esketamine and brexanolone hav...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922941/ https://www.ncbi.nlm.nih.gov/pubmed/36793329 http://dx.doi.org/10.3892/etm.2023.11810 |